The NIH panel recommends increased research funding and education for healthcare providers to address the diagnostic challenges and limited knowledge surrounding ME/CFS. Recent insights into possible causes, such as brain changes and immune imbalance, offer hope for eventual understanding and effective treatments.
The NIH panel recommends a more tailored approach to treating the estimated 100 million Americans with chronic pain. A combination of evidence-based and multidisciplinary approaches is needed to balance patient perspectives, desired outcomes, and safety.
The NIH panel suggests renaming PCOS due to its association with ovarian cysts, which is neither necessary nor sufficient to diagnose the condition. The new name will enhance recognition of the disorder and facilitate expansion of research support.
An independent panel recommends closely monitoring men with localized, low-risk prostate cancer to delay treatment until disease progression. However, standardizing definitions and conducting additional studies are needed to clarify management strategies and optimize patient outcomes.
An independent panel by the NIH determined that mental stimulation, exercise, and dietary supplements have insufficient evidence to delay or prevent Alzheimer's disease. The panel emphasized the need for research on objective measures of cognitive function and collaboration between clinicians and researchers.
A recent NIH panel has questioned 'VBAC bans' and advocated for expanded delivery options for women. The panel suggests that a trial of labor is a reasonable option for many women with a prior cesarean delivery, citing success rates of nearly 75 percent.
A panel assesses lactose intolerance's public health burden and recommends personalized management strategies to avoid inadequate nutrition. It emphasizes the need for research to better understand the effectiveness of approaches in decreasing symptoms and improving health outcomes.
The NIH is expanding its Rare Diseases Clinical Research Network with a new $117 million funding round. The network aims to understand the natural history, epidemiology, diagnosis, and treatment of over 95 rare diseases through clinical studies involving more than 5,000 patients.
The NIH panel found that the routine collection of family history may motivate positive lifestyle changes and enhance individual empowerment, but its effectiveness in improving health outcomes is unclear. The panel recommends additional research to understand how to effectively gather and use family history information in primary care.
The NIH convened a panel to weigh evidence on hepatitis B management, highlighting the need for large studies and representative prospective cohort studies. The panel recommends routine screening for newly arrived immigrants from countries with high hepatitis B prevalence.
A NIH panel emphasizes the importance of removing stigma associated with fecal and urinary incontinence, recommending increased public awareness and provider education. The panel also highlights the need for research studies to fill knowledge gaps and develop effective prevention and treatment strategies.
The NIH panel advocates for expanded regulation of vitamins and minerals, calling for changes in FDA's authority to ensure quality production and consumer reporting of adverse events. The panel also recommends rigorous randomized trials and new MVM databases to test efficacy and safety.
The sixth issue of the Bibliography includes abstracts of 25 significant dietary supplement research papers published in 2004. It highlights research on phenolics and flavonoids, reflecting growing interest in their potential health effects.
The NIH will hold a Consensus Development Conference on Osteoporosis Prevention, Diagnosis, and Therapy, bringing together experts to discuss the latest research findings. The conference aims to clarify factors associated with prevention and better diagnosis and treatment of osteoporosis.